Tiltbio’s highly regarded and experienced team has grown to 20 professionals with decades of experience in the research, development, and commercialization of cancer therapeutics. The company is headquartered in Finland (TILT Biotherapeutics Oy) with a fully owned subsidiary in the U.S. for the local clinical operations.
Strategic Advisors
Tiltbio’s advisors bring their senior industry expertise from Europe and the U.S. for the support of the operational team and the company strategy.
Tuija Keinonen
Pharm PhD, Professor of Practice, Chair of the Board of Directors, Advisor - Operational Exellence
These are the principles that guide our work:
Board of Directors
Tiltbio’s Board includes leading authorities and serial entrepreneurs in the life sciences, legal, financial, and pharmaceutical fields. The board is chaired by Tuija Keinonen (PhD, Profesor of Practice).
Tuija Keinonen
Pharm PhD, Professor of Practice, Chair of the Board of Directors, Advisor - Operational Exellence
Scientific Advisors
Tiltbio’s scientific and clinical advisors include prominent clinicians and researchers from cancer-focused institutions across Europe and the U.S. In addition, the company holds indication specific advisory boards.
